ISCTR Donation

$ Donation Amount:

Personal Info

First Name *

Last Name

Email Address *

Credit Card Info

This is a secure SSL encrypted payment.

Card Number *

CVC *

Cardholder Name *

Expiration *

Billing Details

Country *

Address 1 *

Address 2

City *

State *

Zip / Postal Code *

Terms

Acceptance of any contribution, gift or grant is at the discretion of the ISCTR. The International Society for Cardiovascular Translational Research will not accept any gift unless it can be used or expended consistently with the purpose and mission of the ISCTR | International Society for Cardiovascular Translational Research.

No irrevocable gift, whether outright or life-income in character, will be accepted if under any reasonable set of circumstances the gift would jeopardize the donor’s financial security.

International Society for Cardiovascular Translational Research will refrain from providing advice about the tax or other treatment of gifts and will encourage donors to seek guidance from their own professional advisers to assist them in the process of making their donation.

The ISCTR | International Society for Cardiovascular Translational Research will accept donations of cash or publicly traded securities. Gifts of in-kind services will be accepted at the discretion of the ISCTR | International Society for Cardiovascular Translational Research.

Certain other gifts, real property, personal property, in-kind gifts, non-liquid securities, and contributions whose sources are not transparent or whose use is restricted in some manner, must be reviewed prior to acceptance due to the special obligations raised or liabilities they may pose for ISCTR | International Society for Cardiovascular Translational Research.

The ISCTR | International Society for Cardiovascular Translational Research will provide acknowledgments to donors meeting tax requirements for property received by the charity as a gift. However, except for gifts of cash and publicly traded securities, no value shall be ascribed to any receipt or other form of substantiation of a gift received by ISCTR | International Society for Cardiovascular Translational Research.

The ISCTR | International Society for Cardiovascular Translational Research will respect the intent of the donor relating to gifts for restricted purposes and those relating to the desire to remain anonymous. With respect to anonymous gifts, the ISCTR | International Society for Cardiovascular Translational Research will restrict information about the donor to only those staff members with a need to know.

The ISCTR | International Society for Cardiovascular Translational Research will not compensate, whether through commissions, finders' fees, or other means, any third party for directing a gift or a donor to the ISCTR | International Society for Cardiovascular Translational Research.

Show Terms

Agree to Terms?

Donation Total: $100.00

Home / Translational Pathways For Cardiovascular Devices / Table of Contents

Editors: Nabil Dib, MD; Spencer King, MD; Anthony DeMaria, MD

Contributors

Part I: Basic Concepts In Device Development

Click/Tap a chapter title to enter

I.1	Introduction (Preview Free Article)
	David R. Holmes, MD; Anthony DeMaria, MD; Nabil Dib, MD, MSc; Spencer King III, MD; David G. Reuter, MD, PhD
I.2	Overview of Cardiovascular Translational Research (Preview Free Article & Lectures From Doctors Dib & Califf)
	Nabil Dib, MD, MSc
I.3	A Needs-Based Approach to Health Technology Innovation: The Stanford Biodesign Process Concept Development for Unmet Clinical Needs
	Todd J. Brinton, MD; Uday N. Kumar, MD; Jonathan G. Schwartz, MD; Paul G. Yock, MD
I.4	Intellectual Property and Strategy Development
	Neil K. Nydegger, Esq
I.5	Business Planning, Product Development and Fundraising: The Three Amigos of Your Device Start-Up
	Stanton Rowe
I.6	Regulatory Requirement for Marketing Approval
	Felipe Aguel; Deborah G. Castillo, PhD; Joseph Chin, MD; Bram D. Zuckerman, MD
I.7	Regulatory Assessment of Medical Devices in the European Union
	Alan G. Fraser, MD; Robert A. Byrne, PhD; Tom Melvin, MD; Niall MacAleenan, MD; Olga Tkachenko, PhD; Paul Piscoi, MD
I.8	Requirements for Reimbursement for Innovation
	Joseph Chin, MD; Seth Clancy
I.9	The ABCs of Reimbursement for Breakthrough Devices
	Tonya Dowd, MPH; Simran Madhani
I.10	Requirement for New Technology to be Included in the Guidelines: “The Ultimate Goal”
	Alice Jacobs, MD
I.11	Advanced Biostatistics for Translational Research
	Chris Mullin; Roseann White
I.12	Early Feasibility Studies
	Andrew Farb, MD; David G. Reuter, MD, PhD

Part II: Translational Pathway For Transcatheter Aortic Valves

Click/Tap a chapter title to enter

II.1	Introduction (Preview Free Article & Lectures From Doctors Cribier & Leon)
	Stanton Rowe
II.2	Unmet Clinical Needs
	Martin B. Leon, MD
II.3	Preclinical Evaluation for TAVR
	Sarah Ahlberg, Carol E. Eberhardt, Russell Hodge, Timothy Kelley, Jeffrey Kepner, Hatem Tadros
II.4	Clinical Evaluations – Methods
	Nicole Ibrahim, PhD
II.5	Clinical Evaluations – Endpoints
	Ori Ben-Yehuda, MD
II.6	Reimbursement
	Seth Clancy
II.7	Future of TAVR Devices
	Stanton Rowe

Part III: Translational Pathway For Transcatheter Mitral And Tricuspid Valve Development

Click/Tap a chapter title to enter

III.1	Introduction
	Blasé Carabello, MD
III.2	Unmet Clinical Needs
	Blasé Carabello, MD
III.3	Preclinical Evaluation of Percutaneous Mitral/Tricuspid Valve Repair/Replacement
	Patrick Verta, MS, DVM, MD
III.4	Clinical Evaluations – Methods
	John Laschinger, MD
III.5	Clinical Evaluations – Endpoints
	Blasé Carabello, MD; Anthony DeMaria, MD; David Holmes, MD; Spencer King III, MD; John Laschinger, MD; Patrick Verta, MS, DVM, MD
III.6	Reimbursement
	Christopher J. Panarites, PhD; Elizabeth Thoma, MBA
III.7	Future of Mitral and Tricuspid Devices
	Paul Grayburn, MD

Part IV:Translational Pathway For Coronary Stent Development

Click/Tap a chapter title to enter

IV.1	Introduction
	Chuck Simonton, MD
IV.2	Unmet Clinical Needs
	Stephen Ellis, MD; Chuck Simonton MD
IV.3	Preclinical Evaluation of Coronary Stents
	Laura E. Leigh Perkins, DVM, PhD, DACVP
IV.4	Clinical Evaluations – Methods
	Priya Jagasia, MD; Chuck Simonton, MD
IV.5	Clinical Evaluations – Endpoints
	Donald E. Cutlip, MD
IV.6	Reimbursement
	Chuck Simonton, MD
IV.7	Future of Coronary Stents
	Mitchell W. Krucoff, MD

Part V: Translational Pathway For Ventricular Assist Devices

Click/Tap a chapter title to enter

V.1	Introduction
	Francis D. Pagani, MD
V.2	Unmet Clinical Needs
	Francis D. Pagani, MD
V.3	Preclinical Evaluation of VADs
	Kevin Bourque; Changfu Wu, PhD
V.4	Clinical Evaluations – Methods
	Francis D. Pagani, MD; Changfu Wu, PhD
V.5	Clinical Evaluations – Endpoints
	David J. Farrar, PhD; Philip B. Adamson, MD, MSc
V.6	Reimbursement
	Robin Bostic
V.7	Future of VADs
	Francis D. Pagani, MD

Part VI: Translational Pathway for Catheter Ablation

Click/Tap a chapter title to enter

VI.1	Introduction
	Gregory K. Feld, MD
VI.2	Unmet Clinical Needs
	Gregory K. Feld, MD
VI.3	Preclinical Evaluation for Catheter Ablation
	Tim Laske, PhD
VI.4	Clinical Evaluations
	Marco Cannella, PhD
VI.5	Reimbursement
	Tonya Dowd, MPH
VI.6	Future of Catheter Ablation
	Gregory K. Feld, MD

Part VII: Supplemental Chapters

Click/Tap a chapter title to enter

VII.1	Advanced Cardiac Anatomy: Application in Translational Research Tailored to Current and Future Technology
	Renu Virmani, MD
VII.2	Introduction to the Cardiac Catheterization Laboratory
	Morton Kern, MD

ISCTR Donation

Editors: Nabil Dib, MD; Spencer King, MD; Anthony DeMaria, MD

Part I: Basic Concepts In Device Development

Part II: Translational Pathway For Transcatheter Aortic Valves

Part III: Translational Pathway For Transcatheter Mitral And Tricuspid Valve Development

Part IV:Translational Pathway For Coronary Stent Development

Part V: Translational Pathway For Ventricular Assist Devices

Part VI: Translational Pathway for Catheter Ablation

Part VII: Supplemental Chapters

Contact Info

Helpful Links